Clinical Trial Update: An Exploratory Clinical Study on Neoadjuvant Treatment of Hepatocellular Carcinoma with QL1706 Combined with Lenvatinib [Phase 2]

View source ↗

Summary

An exploratory Phase 2 clinical trial evaluating neoadjuvant treatment of hepatocellular carcinoma with QL1706 in combination with lenvatinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)
• QL1706

Snippet

Sponsor: Northern Jiangsu People's Hospital | Conditions: HCC - Hepatocellular Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING